U.S. Army Special Operations Command Units Ceasing Use of Mefloquine

The following document was originally published by Rita O’Reilly and reportedly obtained via Dr. Remington Nevin. Mefloquine is an anti-malarial drug that has been linked to brain damage and was recently given a black box warning label by the FDA stating that the drug is linked to neurological symptoms “such as dizziness or vertigo, tinnitus, and loss of balance” as well as everything from “anxiety, paranoia, and depression, to hallucinations and psychotic behavior.” The warning states that these “adverse reactions may occur early in the course of mefloquine use and in some cases have been reported to continue for months or years after mefloquine has been stopped.” A recent article by Jason Leopold for Al Jazeera America states that after the FDA’s updated warning in July the DoD ordered a review to determine whether “heavy doses” of the drug given to prisoners held in Guantanamo Bay between January 2002 and mid-2005 may have caused brain damage.